SCHEDULE 13G FOR DECEMBER 31, 2007

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

January 25, 2008

Accession Number

0001095449-08-000008

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →